Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia
- PMID: 8536364
- PMCID: PMC1553363
- DOI: 10.1111/j.1365-2249.1995.tb03844.x
Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia
Abstract
To determine whether circulating levels of any of the colony-stimulating factors (CSF) might contribute to the host response in severe sepsis, plasma concentrations of granulocyte CSF (G-CSF), granulocyte-macrophage CSF (GM-CSF), and macrophage CSF (M-CSF) were measured by immunoassays in 20 subjects with meningococcaemia, a bloodstream infection caused by Neisseria meningitidis, that has proven to be a valuable model to study the responses of other inflammatory mediators during sepsis and septic shock in humans. Plasma G-CSF concentrations were transiently elevated in most subjects during the early phase of meningococcaemia, and were higher in subjects with septic shock (mean +/- s.d. = 165 +/- 142 ng/ml, n = 9) compared with those who remained normotensive (mean +/- s.d. = 7 +/- 2 ng/ml, n = 10) (P < 0.05). Peak plasma G-CSF concentrations > 10 ng/ml were associated with the development of septic shock (P < 0.01), disseminated intravascular coagulation (P < 0.01), fulminant infection (P < 0.05), and a fatal outcome (P < 0.01). Plasma GM-CSF concentrations > 1 ng/ml were briefly present in subjects with life-threatening septic shock (1-15 ng/ml, n = 5), and were strongly associated with fulminant meningococcaemia (P < 0.01). Plasma M-CSF concentrations were marginally elevated in all subjects, but were not associated with complications related to or arising from sepsis-induced organ injury. This study demonstrates that plasma levels of G-CSF, GM-CSF and M-CSF show very different responses during meningococcaemia, changes which presumably reflect the different roles played by these mediators in sepsis and, potentially, in septic shock.
Similar articles
-
Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.Crit Care Med. 2000 Jul;28(7):2344-54. doi: 10.1097/00003246-200007000-00028. Crit Care Med. 2000. PMID: 10921563
-
Endogenous haemopoietic growth factors in neutropenia and infection.Br J Haematol. 1994 Feb;86(2):265-74. doi: 10.1111/j.1365-2141.1994.tb04725.x. Br J Haematol. 1994. PMID: 7515265
-
Differential alterations in plasma colony-stimulating factor concentrations after coronary artery bypass graft surgery with extracorporeal circulation.Cytokine. 2001 Mar 7;13(5):314-6. doi: 10.1006/cyto.2000.0834. Cytokine. 2001. PMID: 11243710
-
Regulation of myeloid development and function by colony stimulating factors.Dev Comp Immunol. 2004 May 3;28(5):509-54. doi: 10.1016/j.dci.2003.09.010. Dev Comp Immunol. 2004. PMID: 15062647 Review.
-
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.J Infect Dis. 1999 Mar;179 Suppl 2:S342-52. doi: 10.1086/513857. J Infect Dis. 1999. PMID: 10081506 Review.
Cited by
-
Perioperative recombinant human granulocyte colony-stimulating factor (Filgrastim) treatment prevents immunoinflammatory dysfunction associated with major surgery.Ann Surg. 2004 Jan;239(1):75-81. doi: 10.1097/01.sla.0000103062.21049.82. Ann Surg. 2004. PMID: 14685103 Free PMC article. Clinical Trial.
-
Update on meningococcal disease with emphasis on pathogenesis and clinical management.Clin Microbiol Rev. 2000 Jan;13(1):144-66, table of contents. doi: 10.1128/CMR.13.1.144. Clin Microbiol Rev. 2000. PMID: 10627495 Free PMC article. Review.
-
Monocyte-macrophage membrane expression of IL-1R2 is a severity biomarker in sepsis.Cell Death Dis. 2025 Apr 10;16(1):269. doi: 10.1038/s41419-025-07597-x. Cell Death Dis. 2025. PMID: 40204720 Free PMC article.
-
Emergency granulopoiesis.Nat Rev Immunol. 2014 May;14(5):302-14. doi: 10.1038/nri3660. Epub 2014 Apr 22. Nat Rev Immunol. 2014. PMID: 24751955 Review.
-
The discovery, development and clinical applications of granulocyte colony-stimulating factor.Trans Am Clin Climatol Assoc. 1998;109:27-36; discussion 36-8. Trans Am Clin Climatol Assoc. 1998. PMID: 9601125 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials